TabAdult & adolescent >12 yr 10 mg once daily. Childn 6-12 yr 5 mg bid. SyrAdult & adolescent >12 yr 10 mL once daily. Childn 6-12 yr 5 mL bid, 2-6 yr 2.5 mL bid. Renal impairment CrCl ≥80 mL/min 10 mg once daily, 50-79 mL/min 10 mg once daily, 30-49 mL/min 5 mg once daily, <30 mL/min 5 mg once every 2 days.
Hypersensitivity to cetirizine, hydroxyzine or any piperazine derivatives. Severe renal impairment at CrCl <10 mL/min or end-stage renal disease. Tab: Rare hereditary problems of galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption. Not to be used in childn <6 yr.
Patients w/ predisposition factors of urinary retention (eg, spinal cord lesion, prostatic hyperplasia), epileptic patients & patients who are at risk of convulsions. Observe a wash-out period of 3 days before performing allergy skin tests. Pruritus &/or urticaria. Alcohol. Pregnancy & lactation. Childn.